Galecto shelves high dose of IPF drug after SAE imbalance; Longtime Aveo partner hands back HER3 antibody
Galecto $GLTO is yanking the top dose of its IPF drug GB0139 in a clinical study after the safety monitoring board flagged an
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
